Measuring parathyroid hormone (PTH) is indicated in the evaluation of calcium metabolism disorders, monitoring patients with chronic kidney disease, and, in rare cases, investigating secondary osteoporosis. Elevated calcium levels along with increased PTH concentrations are observed in primary hyperparathyroidism. Secondary hyperparathyroidism occurs with hypocalcemia, vitamin D deficiency, and kidney disease. Low PTH concentrations are seen in primary hypoparathyroidism, severe hypo- or hypermagnesemia, and hypercalcemia caused by factors other than primary hyperparathyroidism.
References:
- Brukerhåndbok i medisinsk biokjemi OUS, https://ous.labfag.no/?book_request=ousbiokjemi)
- Schmitt CP, Schaefer F, Bruch A, Veldhuis JD, Schmidt-Gayk H, Stein G, Ritz E, Mehls O. Control of pulsatile and tonic parathyroid hormone secretion by ionized calcium. J Clin Endocrinol Metab. 1996 Dec;81(12):4236-43. PMID: 8954021.